Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Kiora Pharmaceuticals, Inc. (KPRX) had Stock-Based Compensation of $0.75M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-13.04M |
|
-- |
|
-- |
|
$12.59M |
|
$-12.59M |
|
$0.16M |
|
$-12.42M |
|
$-12.40M |
|
$-12.51M |
|
$-12.51M |
|
$-12.51M |
|
$-12.49M |
|
$-12.59M |
|
$-12.54M |
|
0.54M |
|
0.54M |
|
$-24.21 |
|
$-24.21 |
|
| Balance Sheet Financials | |
$4.74M |
|
$0.01M |
|
$8.97M |
|
$13.71M |
|
$1.63M |
|
-- |
|
$5.97M |
|
$7.60M |
|
$6.11M |
|
$-2.70M |
|
$6.11M |
|
0.86M |
|
| Cash Flow Statement Financials | |
$-9.56M |
|
-- |
|
$5.97M |
|
$6.01M |
|
$2.46M |
|
$-3.55M |
|
|
Stock-Based Compensation |
$0.75M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-204.82% |
|
462.76% |
|
-91.26% |
|
-204.82% |
|
$7.14 |
|
$-17.77 |
|
$-17.77 |
|